Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
immunotherapy
5
×
indiana blog main
indiana top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
5
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
fda
national
amgen
glaxosmithkline
novartis
abeona therapeutics
aimmune therapeutics
akcea therapeutics
bristol-myers squibb
cancer
cancer immunotherapy
clovis oncology
What
roundup
bio
cancer
drug
abbvie’s
according
advantages
agency
ahead
aimmune
akcea
allergy
annual
approval
approved
ash
awarded
bar
barcelona
biofourmis
biotech
brings
bucks
cases
celebrate
centers
chance
cigarettes
clinical
conference
control
corner
day
days
deaths
december's
developed
disease
electronic
esmo
Language
unset
5
×
Current search:
immunotherapy
×
unset
×
" san diego top stories "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
